|
Behind the Guidelines: Insights into the Standard of Care in Oncology 2026 (NCCN Guidelines® Insights 2026) |
|
01/10/2026 - 12:00am to 12/31/2027 - 11:59pm |
|
NCCN Tumor Boards: Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma |
1.00 |
01/20/2026 - 12:00am to 07/19/2026 - 12:00am |
|
NCCN Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology |
|
01/21/2026 - 12:00am to 12/30/2027 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric Acute Lymphoblastic Leukemia |
1.00 |
01/21/2026 - 9:43am to 07/11/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - When Prognosis Changes from Good to Poor: Treatment Options for Richter Transformation of Chronic Lymphocytic... |
1.00 |
01/22/2026 - 12:00am to 07/25/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation |
1.00 |
02/05/2026 - 12:00am to 01/26/2027 - 11:59pm |
|
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026 |
1.00 |
02/10/2026 - 12:00am to 02/10/2027 - 11:59pm |
|
NCCN Tumor Boards: Optimizing Clinical Decision-Making for Resectable Non-Small Cell Lung Cancer |
1.00 |
02/13/2026 - 12:00am to 07/26/2026 - 12:00am |
|
NCCN Optimizing Patient Outcomes - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations |
1.00 |
02/27/2026 - 12:00am to 08/16/2026 - 11:59pm |
|
Archived NCCN Tumor Boards: Optimizing Treatment of Chronic Phase Chronic Myeloid Leukemia |
1.00 |
03/09/2026 - 12:00am to 02/24/2027 - 11:59pm |
|
NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026 |
1.00 |
03/10/2026 - 12:00am to 03/10/2027 - 11:59pm |
|
Recorded Presentations from the NCCN 2026 Breast Cancer Congress with Updates from the 2025 San Antonio Breast Cancer Symposium |
|
03/15/2026 - 12:00am to 03/14/2027 - 11:59pm |
|
NCCN 2026 Annual Conference: In-Person Attendance |
20.25 |
03/29/2026 - 10:30am to 06/30/2026 - 11:59pm |
|
NCCN 2026 Annual Conference: Virtual Attendance |
16.25 |
03/29/2026 - 10:30am to 06/30/2026 - 11:59pm |
|
NCCN Guidelines® Insights - Merkel Cell Carcinoma, Version 1.2024 (JA copy) |
1.00 |
04/01/2026 - 12:00am to 12/31/2026 - 11:59pm |
Facebook
X
LinkedIn
Forward